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Abstract
Background: GIMAP (GTPase of the immunity-associated protein family) proteins are a family of
putative GTPases believed to be regulators of cell death in lymphomyeloid cells. GIMAP1 was the
first reported member of this gene family, identified as a gene up-regulated at the RNA level in the
spleens of mice infected with the malarial parasite, Plasmodium chabaudi.
Methods: A monoclonal antibody against mouse GIMAP1 was developed and was used to analyse
the expression of the endogenous protein in tissues of normal mice and in defined sub-populations
of cells prepared from lymphoid tissues using flow cytometry. It was also used to assess the
expression of GIMAP1 protein after infection and/or immunization of mice with P. chabaudi. Real-
time PCR analysis was employed to measure the expression of GIMAP1 for comparison with the
protein level analysis.
Results: GIMAP1 protein expression was detected in all lineages of lymphocytes (T, B, NK), in F4/
80+ splenic macrophages and in some lymphoid cell lines. Additional evidence is presented
suggesting that the strong expression by mature B cells of GIMAP1 and other GIMAP genes and
proteins seen in mice may be a species-dependent characteristic. Unexpectedly, no increase was
found in the expression of GIMAP1 in P. chabaudi infected mice at either the mRNA or protein
level, and this remained so despite applying a number of variations to the protocol.
Conclusion: The model of up-regulation of GIMAP1 in response to infection/immunization with
P. chabaudi is not a robustly reproducible experimental system. The GIMAP1 protein is widely
expressed in lymphoid cells, with an interesting increase in expression in the later stages of B cell
development. Alternative approaches will be required to define the functional role of this GTPase
in immune cells.
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Background
GIMAP1 (GTPase of the immunity-associated protein
family 1; formerly known variously as iap38, imap38,
IAN2) was the first reported member of a family of puta-
tive GTPases [1]. These are present in vertebrates, absent
from bacteria, nematodes and flies but with relatives in
higher plants [2-5]. Humans, rats and mice have seven or
eight GIMAP genes clustered tightly on a single autosome.
The predicted proteins encoded by these genes are similar
in their amino-terminal regions, which contain a guanine
nucleotide binding domain with conserved motifs, but
vary significantly at their carboxy-terminal ends, which
contain predicted coiled-coil regions or transmembrane
(TM) domains, or both [2].
GIMAP1 was originally discovered in a differential screen
of a spleen cell cDNA library made from malaria (Plasmo-
dium chabaudi)-immune mice using cDNA from immune
or non-immune mouse spleens [1]. In this and a later
publication [6], the authors reported Northern blot com-
parisons of spleen mRNAs from mice either before, or
seven days after, malaria infection, using both naïve and
malaria-immune animals. GIMAP1 expression, which was
relatively weak in naïve mouse spleen, was increased two
to 30-fold post infection in various mouse strains on the
C57BL/10 or C57BL/6 backgrounds and was high in
spleens of immune mice both pre- and post-infection.
Post-infection expression levels were particularly high in
the plastic-adherent splenocyte fraction ('macrophages')
and successively weaker in B and T cells [1].
GIMAP proteins are thought to be involved in the regula-
tion of cell death. The evidence for this has come from
family members other than GIMAP1, in particular
GIMAP5 and GIMAP4. Diverse evidence from in vivo and
in vitro systems in rat, mouse and human has indicated
that GIMAP5 has anti-apoptotic properties, notably in the
T lymphocyte lineage [4,7-11]. Pro-death properties, by
contrast, have been ascribed to GIMAP4, from studies in
both mouse and rat [4,12,13]. Consistent with the
involvement of GIMAP4 and GIMAP5 in the regulation of
cell survival, both proteins have been shown to be capable
of interacting physically with members of the Bcl-2 family
of proteins [4].
It was important to find out whether the up-regulation of
GIMAP1 during malaria infection in mice was indicative
of regulated apoptotic processes occurring during the
immune response to this pathogen or, instead, reflected a
distinct biological function for this member of the GIMAP
family. The initial aim of this investigation was to gener-
ate antibodies specific for mouse GIMAP1, in order to
study the expression of this GTPase at the protein level
and learn more about the nature of the cells expressing it
in both naïve and malaria-immune or -infected mice. A
surprising outcome of this study, which made use of a
novel monoclonal antibody (mAb) against mouse
GIMAP1, was the failure, despite extensive efforts, to
reproduce the up-regulation of GIMAP1 as reported in
earlier publications [1,6].
Methods
Animals
C57BL/6 and C57BL/10ScSn mice for malaria experi-
ments were bred and used at the National Institute for
Medical Research; C57BL/6 mice and PVG-RT1u, RT7b rats
for other experiments were bred at The Babraham Insti-
tute. LOU/C rats were obtained from Harlan UK. All ani-
mals were maintained in specific pathogen-free
conditions. All husbandry and experimentation complied
with UK Home Office licences and local standards in force
at the respective institutions.
Cell lines used
The mouse cell lines C1498, A20, TK-1, P815, BW5147,
MTC-1, RMA, X16.C8.15 and YAC-1 were maintained in
RPMI (Invitrogen) supplemented with 10% foetal calf
serum (FCS), 100 units/ml penicillin and 100 μg/ml
streptomycin (Invitrogen) and 25 μM β-mercaptoethanol.
The mouse cell line EL4 was grown in DMEM (Invitro-
gen), supplemented as above. HEK293T cells were main-
tained in the same medium as EL4 but without the
addition of β-mercaptoethanol.
Generation of monoclonal and polyclonal antibodies
Mouse GIMAP1 was cloned into pENTR™/TEV/D-TOPO
(Invitrogen) and then transferred into the Gateway
pDEST15 vector using Gateway LR Clonase II Enzyme Mix
(Invitrogen), in accordance with the manufacturers'
instructions. In order to exclude the predicted TM domain
from any expressed fusion protein product, codon 239 of
the open reading frame was converted to a stop (TAA) by
polymerase chain reaction (PCR) with the primers 5'-
CCCAGGACCAATAAGCCAAGGTGG-3' and 5'-CCAC-
CTTGGCTTATTGGTCCTGGG-3'. A fusion protein with
glutathione-S-transferase (GST) N-terminal of mouse
GIMAP1 was expressed in Escherichia coli Rosetta DE3
(Novagen) in inclusion bodies. These were solubilized in
6 M urea and the fusion protein was purified using
sodium dodecyl sulphate-polyacrylamide gel electro-
phoresis (SDS-PAGE) followed by electro-elution from
the gel using an electrophoretic concentrator (Isco Inc.,
Lincoln, Nebraska USA). A female LOU/C rat was immu-
nized subcutaneously three times at three to four-weekly
intervals with 50–100 μg of the fusion protein in Freund's
adjuvant. A final, intrasplenic, boost was delivered in an
aqueous vehicle. Three days later the rat was killed and
spleen cells were fused with the rat Y3Ag1.2.3 plasmacy-
toma [14] to generate hybridomas. Hybridoma superna-
tants were screened by western blotting on lysates ofMalaria Journal 2009, 8:53 http://www.malariajournal.com/content/8/1/53
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HEK293T cells expressing myc-tagged mouse GIMAP1
(see below). The selected positive hybridoma, MAC420,
secretes a rat IgG2a antibody. An anti-mouse GIMAP1 rab-
bit polyclonal antibody was custom produced by Harlan
Sera-Lab (Loughborough, UK) using the same immuno-
gen.
Generation of epitope-tagged constructs
N-terminally myc-tagged GIMAP constructs (with the
exception of mGIMAP4) were generated by cloning PCR
products amplified from GIMAP cDNA, or previously
cloned plasmids, into pCANmyc1 (derivative of pcDNA3
which includes an ATG and encodes an in-frame myc tag
at the 5' end of the multiple cloning site; provided by Dr
Simon Cook). Mouse GIMAP4 was C-terminally myc-
tagged by cloning into pcDNA3.1 (-)/myc-HIS A (Invitro-
gen). The primers used are listed in Table 1.
Transient transfections
Confluent cultures of HEK293T cells were harvested and
plated out at 1.5 × 106 cells per 35 mm dish. For transfec-
tions, 2 μg of plasmid DNA were diluted to 50 μl with 150
mM NaCl. Fifty microlitres of 8% (v/v) jetPEI® (Autogen
Bioclear) in 150 mM NaCl were added to the DNA and the
mixture was incubated at room temperature for 30 min.
The DNA-jetPEI® complexes were added to the HEK293T
cells which were then incubated for 24 hours at 37°C, 5%
CO2. The cells were washed in phosphate buffered saline
(PBS) and then lysed on ice for 10 min in 10 mM N-2-
hydroxyethylpiperazine-N'-2-ethanesulphonic acid
(HEPES), 150 mM NaCl, 1% (w/v) 3- [(3-cholamidopro-
pyl) dimethylammonio]-1-propanesulphonate (CHAPS)
pH7.5 containing 1:100 protease inhibitors for mamma-
lian cells (Sigma). Insoluble cell debris was removed by
centrifugation at 15,000 g at 4°C for 5 min and lysates
were then diluted 1:1 with Laemmli sample buffer (Bio-
Rad) containing 100 mM dithiothreitol.
Preparation of lysates from cell lines and tissues
Cells were lysed at 106 cells per 5 μl of lysis buffer (2%
NP40, 1 mM MgCl2, 20 mM 2-amino-2-hydroxymethyl-
1,3-propanediol [Tris], 150 mM NaCl, pH 8.0, containing
protease inhibitors for mammalian cells [Sigma]) and
incubated on ice for 30 min. Cell debris was removed by
centrifugation at 15,000 g, 4°C for 10 min. The superna-
tant was transferred to a fresh microfuge tube, and an
equal volume of Laemmli sample buffer, containing 100
mM dithiothreitol, was added. Unless otherwise stated,
lysate from 1 × 106 cells was used per lane of a polyacryla-
mide gel.
Tissues from male C57BL/6 mice were homogenized into
lysis buffer using a Dounce homogenizer. Cell debris was
removed as above. Protein concentrations were measured
using the bicinchoninic acid assay (BCA) Protein Quanti-
fication kit (Pierce) and 100 μg of protein from each tis-
sue, in 50% Laemmli sample buffer containing 100 mM
dithiothreitol, was separated by reducing SDS-PAGE.
Table 1: Sequences of oligonucleotide primers for protein expression of GIMAPs: cloning mouse and rat GIMAPs into pCANmyc1 or 
pcDNA3.1(-)/myc-HIS A
Name Forward primer Reverse primer
mGIMAP1 5'-GCATGGAATTCATGG 5'-GATGCGCGGCCGCTT
GAGGAAGGAAGATGG-3' ATCTGTTATTCTGGT-3'
mGIMAP1 5'-GCATGGAATTCATGG 5'-CTATCTCGAGTCCAG
aa1-aa158 GAGGAAGGAAGATGG-3' CCAGGTCCTCTTGGC-3'
mGIMAP1 5'-CTGAGAATTCGACAC 5'-CTATCTCGAGTTGGT
aa81-aa238 CCCGGATATCTTCAG-3' CCTGGGGGTCAGCGC-3'
mGIMAP3 5'-GCGGAATTCATGGAA 5'-GCGGCGGCCGCTTAA
ACACTTCAGAATG-3' ACATAAAATAAGAG-3'
mGIMAP4 5'-GCGGGATCCCATGGA 5'-GCGGGATCCCTAGTC
AGTCCAGTGCGGTGG-3' TTTCATAAACTGG-3'
mGIMAP5 5'-GAAACTGAATTCATGGAACAC 5'-CTTTGAGCGGCCGCACAAGGA
CTTCAGAAGAG CACATATGG-3' TGATGGAAGAAA TCACCC-3'
mGIMAP6 5'-GATCGGATCCAAGAT 5'-GGTCGAATTCTGGTT
GGATTGGCTTTACAGAA-3' ACAGTGTCTTGCTGG-3'
mGIMAP7 5'-CGTAGAATTCATGGCT 5'-CATAGCGGCCGCAAT
GGCCAGGGAGACACT-3' TTACCACAACTCGTCCC-3'
mGIMAP8 5'-GCGTGAATTCATGGC 5'-CGCGCTCGAGTCATT
GACTTCATCCCACCAAG GAG-3' TAAATGCCATAGTAATT TGG-3'
mGIMAP9 5'-CTATGGATCCATGGC 5'-GGTCGAATTCTGCTT
TGAGCCCAGTGACAAC-3' ATGAAAAAAGATGCC-3'
rGIMAP1 5'-CTTCGGATCCATGGG 5'-GTCAGAATTCCTGTT
GGGAAGAAAGATGGTG-3' ACTCTGGTCCCCAAAGG-3'Malaria Journal 2009, 8:53 http://www.malariajournal.com/content/8/1/53
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Western blotting
Samples run on 10% polyacrylamide gels were then trans-
ferred to Immobilon P (Millipore) membrane by semi-dry
blotting. Membranes were blocked overnight in 4% (w/v)
milk powder in PBS containing 0.1% (v/v) Tween 20. Pri-
mary antibodies – rat mAb MAC420 anti-mGIMAP1, rat
mAb MAC417 anti-mouse/rat GIMAP4 [11], rabbit anti-
mGIMAP1 polyclonal serum, rabbit anti-rat GIMAP8 pol-
yclonal serum [15], mouse mAb 9E10 anti-myc tag (pre-
pared in-house) and mouse mAb AC-15 anti-β-actin
(ascitic fluid, Sigma) – were incubated on the membrane
in the blocking solution for 1 hr, before repeated washing
with PBS containing 0.1% (v/v) Tween 20. Secondary
antibodies (horseradish peroxidase [HRP]-conjugated
goat anti-rat IgG (Jackson), HRP-goat anti-rabbit IgG
(DAKO Cytomation) or HRP-goat anti-mouse IgG (Sigma
A4416)) were similarly applied. The membranes were
washed as previously described and developed with the
West Pico SuperSignal Reagent (Pierce). Where applied,
densitometirc quantification of Western blot bands was
performed using a Labworks 4 Bioimaging System (UVP).
Purification of cell populations by fluorescence-activated 
cell sorting (FACS)
Single cell suspensions were prepared from mouse spleen,
thymus, bone marrow or lymph nodes and, if required,
red blood cells were lysed using 3 mM Tris, 140 mM
NH4Cl, pH 7.2 for 10 min at 37°C. Cells were washed
with PBS containing 5% FCS and then incubated with pri-
mary antibodies for 30 min on ice. After further washing
with PBS-5% FCS, they were incubated with secondary
antibodies for 30 min on ice in the dark. The cells were
finally washed again and passed through a 40 μm filter
before being sorted using a FACSAria® (BD Biosciences).
MAbs against the following mouse cell surface markers
were used: B220 (RA3-6B2, BD Pharmingen, biotin- or
allophycocyanin-conjugated), CD4 (YTS177 or YTS191.1,
gifts from Dr Jenny Phillips; biotin-conjugated in-house),
F4/80 antigen (Serotec, biotin-conjugated); CD3 (KT3 a
gift from Dr Denis Alexander, fluorescein isothiocyanate-
conjugated), CD8 (KT15 or YTS169), IgMb (AF6-78, BD
Pharmingen, fluorescein isothiocyanate-conjugated),
NK1.1 (PK136, BD Pharmingen, R-phycoerythrin-conju-
gated), IgDb (217-170, BD Pharmingen, R-phycoerythrin-
conjugated), CD19 (1D3, BD Pharmingen, R-phycoeryth-
rin-conjugated), CD25 (PC61, BD Pharmingen, R-phyco-
erythrin- or allophycocyanin-conjugated). Cy5.5-
conjugated streptavidin (BD Biosciences) was used as a
secondary reagent to detect the biotinylated antibodies.
The cell populations obtained had purities of between
90–100% by FACS analysis.
Infection with Plasmodium
The clones AS and CB of Plasmodium chabaudi chabaudi
[16] were maintained as frozen stocks and passaged in
mice as described previously [17]. For experiments, mice
were injected intra-peritoneally with 105 or 106 infected
red blood cells (iRBC) diluted in 100 ml Krebs' saline.
Infections were monitored by microscopic examination of
Giemsa-stained thin blood films as described [18].
Erythrocyte ghost preparations
Naïve and infected C57BL/10ScSn mice were exsanguin-
ated and their red blood cells were separated by diluting
the blood with a four-fold excess of RPMI supplemented
with 1 mM HEPES followed by centrifugation on a Per-
coll® cushion (7.4 ml isotonic Percoll® mixed with 2.6 ml
RPMI-1 mM HEPES) at 400 g for 11 min at 15°C with no
brake. The parasitized red blood cells were removed from
the medium-Percoll®  interface and were washed with
Iscove's Complete Medium. Ghosts were prepared in a
manner similar to that described by Wunderlich and col-
leagues [19]. Parasitized red blood cells were concentrated
in Krebs' saline supplemented with 3% FCS. An equal vol-
ume of Glycerol Buffer (10% glycerol, 5% FCS in PBS) was
added and the cells were incubated at room temperature
for 1.5 min. A 4-fold volume of RPMI-5% FCS was added
and the parasites and ghosts were separated on a 1.01–
1.02 g/ml one-step Percoll® gradient which was centri-
fuged at 5000 g for 30 min. Ghosts were recovered from
the top of the gradient, washed with RPMI-5% FCS and
centrifuged again. They were resuspended in phosphate
buffer (5 mM NaH2PO4/NaHPO4, pH 8.5), spun down
and washed again in RPMI-5% FCS, and finally resus-
pended in PBS. Erythrocyte ghosts from 1 × 107 red blood
cells were used per mouse for subcutaneous immuniza-
tion in complete Freund's adjuvant. Seven days post-
immunization, some of the mice were infected with 106
parasitized red blood cells as described above. Nine weeks
after this infection the mice were infected again, and seven
days later mice were taken as "immune".
Preparation of cDNA
Total RNA was extracted from cells using TRIZOL reagent
(Invitrogen) and was used to generate first-strand cDNA
using SuperScript III RNase H- reverse transcriptase (Invit-
rogen).
Real-time PCR
Real-time PCR reactions were carried out as described pre-
viously, using cirhin and 6-phosphofructokinase C as con-
trol genes [15]. The primers used are listed in Table 2.
Results
A monoclonal antibody specific for mouse GIMAP1
A rat mAb, MAC420, was generated against a recombinant
mouse GIMAP1 fusion protein. The specificity of this anti-
body was assessed by western blots of lysates from a series
of transiently-transfected HEK293T cells expressing differ-
ent myc-tagged GIMAP constructs, including a full set ofMalaria Journal 2009, 8:53 http://www.malariajournal.com/content/8/1/53
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the mouse GIMAP family (Figure 1A). MAC420 detected
full-length mouse GIMAP1, but not the rat homologue. It
reacted selectively with GIMAP1, failing to detect any of
the other mouse GIMAPs. The antibody reacted with a
myc-tagged construct containing predicted amino acids
81–238 but not with a construct containing predicted
amino acids 1–158 of mGIMAP1, suggesting that the
epitope for this mAb lies between amino acids 158 and
238 (Figure 1B).
A rabbit antiserum raised against mGIMAP1 was also
tested on the lysates from transiently transfected
HEK293T cells. This polyclonal reagent detected full-
length mouse GIMAP1 and both of the truncated con-
structs described above.
GIMAP1 protein in normal mouse tissues
Blots of homogenized tissues from male C57BL/6 mice
were probed using the MAC420 antibody. Figure 1C
shows that MAC420 detected a protein of the size
expected for GIMAP1 in tissues of the immune system,
with high levels of expression being found in spleen,
lymph node and thymus. GIMAP1 expression was also
found at high levels in heart, lung and kidney.
Expression of GIMAP1 in cells from spleen, thymus and 
bone marrow
To elucidate which cell types were expressing GIMAP1 in
immune tissues, cell suspensions prepared from male
C57BL/6 mice were separated by FACS and lysates were
gel-separated and western-blotted using MAC420 (Figure
2A). GIMAP1 was found predominantly in the T (CD3+)
and B (B220+) cells of the spleen and to a lesser extent in
the non-T/non-B (CD3- B220-) cell fraction.
Table 2: Sequences of oligonucleotide primers for Real Time PCR analysis of GIMAPs
Name Accession # Forward primer Reverse primer
Internal control genes
6PFKc Y19008 5'-GAGTGGAGC 5'-CACGTTGAGGTA
GGACTTCTGGA-3' GGAATACTTCTGC-3'
Cirhin BC027399 5'-ATTACGATGC 5'-CCACAGTTCCAA
TGCTCTCCGAA-3' GTGATGCG-3'
GIMAP genes
GIMAP1 NM_175860 5'-TTCAGGGACT 5'-TTCCTCATCTCT
GTCAGCAAGAA-3' TGCCATCTTC-3'
GIMAP3 AF337052 5'-GGACTGGCTG 5'-AGGATCCTCAGT
GACCAGAGACT-3' GGCCTTGAC-3'
GIMAP4 NM_174990 5'-GAAAGTTCAA 5'-CCCCAAGGATAC
GGAGCAGCCATGA-3' TGTTCCCTGTT-3'
GIMAP5 NM_175035 5'-GGAACACCTT 5'-TCCTCAGGCAGC
CAGAAGAGCACAT-3' TAGATTCTTGT-3'
GIMAP6 NM_153175 5'-GTGAGCACAG 5'-ACCAGAAGGAGC
ACCTGAGAAGAATC-3' TGCAGTCTCT-3'
GIMAP7 NM_174960 5'-AGAGATCCTGAACT 5'-CATGTCAAGGCA
CTCATTAACTGTTG-3' AGCTGACTCTA-3'
GIMAP8 AB178029 5'-AGCCTTGCGT 5'-TCCCCAGGATAG
CATCAGAGAGAAA-3' TGTTCCCAGTT-3'
GIMAP9 NM_146167 5'-CCTGGTGCAG 5'-CTTAACGTGGAA
TGCTCTCCGAA-3' GCTCTGGAAT-3'
An anti-mouse GIMAP1 monoclonal antibody was produced  that is specific and can detect endogenous mouse GIMAP1 Figure 1
An anti-mouse GIMAP1 monoclonal antibody was 
produced that is specific and can detect endogenous 
mouse GIMAP1. A. N-terminally myc-tagged GIMAP con-
structs were transiently transfected into HEK293T cells. The 
lysates were Western blotted with either an anti-myc anti-
body 9E10 (upper panel) or the anti-GIMAP1 mAb MAC420 
(lower panel). B. The domain structure of mouse GIMAP1 and 
the two truncates used in A. G1-G5 are the GIMAP versions 
of the canonical GTP binding motifs, TM indicates the puta-
tive transmembrane domain. C. Tissues were removed from 
a C57BL/6 mouse, homogenised in lysis buffer and 100 μg of 
protein from each sample was Western blotted with the 
anti-GIMAP1 mAb (MAC420) or anti-β-actin (AC-15). Esti-
mated molecular weights are in kDa.
A
Anti-myc
Anti-GIMAP1
monoclonal
1    3    4   5  6   7  8   9
mGIMAP
mGIMAP1
truncates
r
G
I
M
A
P
1
1
-
1
5
8
8
1
-
2
3
8
37
50
75
25
37
50
75
25
C
T
h
y
m
u
s
S
p
l
e
e
n
L
i
v
e
r
S
k
e
l
e
t
a
l
 
m
u
s
c
l
e
GIMAP1
actin
B
r
a
i
n
H
e
a
r
t
T
e
s
t
i
s
B
o
n
e
 
M
a
r
r
o
w
L
y
m
p
h
 
n
o
d
e
K
i
d
n
e
y
L
u
n
g
37
25
37
50
B
G1-G5
Conserved Box
Putative coiled coil
TM domain
13 0 0
< aa 1-158
aa 81-238>
AIG1 domainMalaria Journal 2009, 8:53 http://www.malariajournal.com/content/8/1/53
Page 6 of 12
(page number not for citation purposes)
Thymocytes were separated into CD4-CD8- double-nega-
tive (DN), CD4+CD8+  double-positive (DP) and
CD4+CD8- or CD4-CD8+ single-positive (SP) populations.
GIMAP1 was detectable in all of these thymocyte popula-
tions at a similar level, which was a level comparable to
that found in splenocytes.
B cells from bone marrow were separated on the basis of
CD25, B220, IgD and IgM expression into pro-B and pre-
BI cells (CD25- B220+ IgD- IgM-), pre-BII cells (CD25+
B220+ IgD- IgM-), immature B cells (CD25- B220+ IgD-
IgM+) and mature B cells (CD25-  B220+  IgD+  IgM+).
GIMAP1 expression was highest in the mature B cells and
at a substantially lower level in the less mature subsets.
Closer investigation of the non-T, non-B fraction of splen-
ocytes revealed that GIMAP1 was expressed at a high level
in NK/NKT (NK1.1+) cells, while there was only a rela-
tively low level of GIMAP1 in splenic macrophages (F4/
80+). This contrasts with the high level of GIMAP1 mRNA
expression attributed to macrophages in malaria-immune
spleen by Krücken and colleagues [1]. GIMAP1 was also
found to be expressed in bone marrow-derived, GM-CSF
cultured, dendritic cells.
GIMAP1 is expressed endogenously in some 
lymphomyeloid cell lines
Lysates from a variety of cultured lymphomyeloid mouse
cell lines were analysed by western blotting using the pol-
yclonal rabbit antiserum against mouse GIMAP1 and with
mAb MAC420 (Figure 2B). GIMAP1 was not expressed in
all of the cell lines tested but was found at significant lev-
els in C1498, an NKT cell line [20], TK-1 (thymoma) and
A20 cells (B cell lymphoma), and at a lower level in P815
cells (mastocytoma). The two serological reagents gave
concordant results.
GIMAP1 was not up-regulated in mice infected with two 
strains of Plasmodium chabaudi: AS and CB
It had previously been reported that GIMAP1 expression,
measured at the mRNA level, was elevated in the spleens
of mice with malaria [1,6]. In order to learn more about
the cellular details of this rise in expression, for which the
mAb MAC420 could be a useful novel tool, C57BL/6 mice
were infected with P. chabaudi AS, or the more virulent CB
strain, for seven days and then killed. Spleens were taken
and mRNA and protein levels were examined. Surpris-
ingly, no up-regulation of GIMAP1 expression was seen at
either the mRNA or protein level, irrespective of the viru-
lence of the parasite or number of parasites used for infec-
tion (Figure 3). GIMAP1 was also not up-regulated in
either male or female mice on days 4, 7 or 12 of infection.
The level of GIMAP1 in other tissues was also examined
and no significant up-regulation was found in heart, brain
or liver.
Mice made immune to malaria did not show elevated 
GIMAP1 levels
To examine whether mice that were "immune" to malaria
had elevated GIMAP1 levels, as had been previously
reported [1], C57BL/10 mice were similarly immunized
with erythrocyte ghosts from infected mice. After seven
days, the mice were infected with P. chabaudi AS and, nine
weeks post infection, re-infected with P. chabaudi AS. On
day 7 after the second infection, the mice were taken as
"immune mice" following the published protocol [1]. At
the protein level, GIMAP1 expression in spleens from
"immune" mice was the same as that observed in mice
given PBS only or Freund's adjuvant only (Figure 4). Var-
ious other combinations of erythrocyte ghost treatment
from infected or naïve mice, and infection or immuniza-
tion with vehicle were tried and no treatment was found
to significantly up-regulate GIMAP1 (Figure 5).
Species variation in GIMAP expression by B cells
The results shown in Figure 2 revealed a difference in
GIMAP1 expression in the T and B cell lineages. Whereas
GIMAP1 is expressed endogenously in various immune cell  populations and in cell lines Figure 2
GIMAP1 is expressed endogenously in various 
immune cell populations and in cell lines. Cells were 
purified from C57BL/6 mice by FACS sorting with markers as 
follows: T cells (CD3+), B cells (B220+), non T/B cells (CD3- 
B220-), DN thymocytes (CD4- CD8-), DP thymocytes 
(CD4+ CD8+), CD4+ SP thymocytes (CD4+ CD8-), CD8+ 
SP thymocytes (CD4- CD8+), Pro B/Pre BI cells (B220+ 
CD25- IgD- IgM-), PreBII cells (B220+ CD25+ IgD- IgM-), 
immature B cells (B220+ CD25- IgD- IgM+), mature B cells 
(B220+ CD25- IgD+ IgM+), NK cells (NK1.1+), macrophages 
(F4/80+). Cell lysates were Western blotted with MAC 420 
anti-GIMAP1 or anti-β actin. B. Lysates from the indicated 
mouse lymphomyeloid cell lines were Western blotted with 
MAC 420 anti-GIMAP1, a rabbit anti-GIMAP1 polyclonal 
antibody or anti-β actin.
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GIMAP1 protein was expressed relatively highly by cells at
all of the stages in T cell development from DN thymo-
cytes to mature splenic T cells, cells in the early stages of B
cell development were found to express it only weakly,
with a significant up-regulation between the immature
and mature B cell stages. In order to find out whether this
was a unique feature of GIMAP1 expression, Real Time-
PCR analysis of the expression of all the GIMAP gene fam-
ily members in B cell development was conducted. The
results showed (Figure 6) an up-regulation in the expres-
sion of all the GIMAP genes during B cell maturation, with
the exception of GIMAP7. It was also notable that the lev-
els of GIMAP mRNA detected in mature B cells exceeded
those for CD4+ lymph node T cells for the same family
members. These results stood in striking contrast to the
results of an analysis of GIMAP gene expression in rats
conducted and published previously [15]. In that study, B
cell expression of each of the GIMAP genes was lower than
that by lymph node T cells. It was of interest to determine
whether this expression difference was also seen at the
protein level. Unfortunately, no antibody suitable for
comparing GIMAP1 protein expression in mouse and rat
lymphocytes was available (the crossreactivity of our rab-
bit polyclonal anti-mGIMAP1 with rat was insufficiently
good). It was possible, however, to compare the expres-
sion of mouse and rat GIMAP4 and GIMAP8 using rea-
gents developed previously, i.e. the crossreactive mAb
MAC417 against GIMAP4 [12] and a polyclonal rabbit
antiserum against rat GIMAP8 [15]. The results (Figure 7)
showed that the expression of GIMAP4 and GIMAP8 pro-
tein is substantially higher in mouse than in rat spleen or
lymph node B cells. The protein expression in mouse B
cells appeared to approach the levels found in T cells of
both species.
Discussion
Recent reports on the functional and biochemical proper-
ties of GIMAP4 and GIMAP5 in mice and rats [4,12,13]
have led to the hypothesis that members of this family are
critical regulators of T cell survival during development,
selection and homeostasis [21]. The evidence for a
requirement for GIMAP5 in T cell generation and survival
is compelling, coming as it does from independent exper-
imental systems. These are, respectively, the analysis of
GIMAP1 is not up-regulated in mice infected with Plasmodium chabaudi AS or CB Figure 3
GIMAP1 is not up-regulated in mice infected with Plasmodium chabaudi AS or CB. C57BL/6 and C57BL/10 mice 
were infected with Plasmodium chabaudi AS or CB (a more virulent strain of the parasite). Seven days post-infection mice were 
culled and the levels of GIMAP1 protein and mRNA were measured. A. GIMAP1 protein levels were measured by Western 
blotting of spleen cell lysates from naïve or infected mice using the GIMAP1 monoclonal antibody (MAC420). Anti-β actin 
served as a loading control. B. The intensities of GIMAP1 bands in the Western blot in A were quantified by densitometry and 
plotted relative to the average intensity of the bands for the C57BL/6 naïve mice. C. and D. RNA was extracted from the spleen 
of each mouse and Real-time PCR was used to measure the levels of GIMAP1 relative to the average of two naïve mice, which 
was set to a value of 1. Bars represent individual mice.
A
0
1
2
3
4
S1
S2
S3
S4
S5
S6
S7
S8
S9
S10
S11
S12
S13
S14
S15
S16
S17
S18
S19
r
e
l
a
t
i
v
e
 
i
n
t
e
n
s
i
t
y
 
o
f
 
b
a
n
d
 
o
n
 
W
e
s
t
e
r
n
 
b
l
o
t
Naive Naive 105 AS 106 AS 106 AS 106 CB 106 CB
BL/6 mice BL/10 mice
B D
0
1
2
3
naïve BL6 10^5 AS 10^6 AS 10^6 CB
r
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
o
f
 
G
I
M
A
P
1
 
m
R
N
A
Naïve BL6 105 AS 106 AS 106 CB
Infected BL/6 mice
0
1
2
3
naïve BL10 10^6 AS 10^6 CB
r
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
 
o
f
 
G
I
M
A
P
1
 
m
R
N
A
106 AS 106 CB Naïve BL10
Infected BL/10 mice
GIMAP1
actin
Naïve
BL/6
Naïve
BL/10
BL/6
105 AS
BL/6
106 AS
BL/6
106 CB
BL/10
106 AS
BL/10
106 CB
37
25
37
50
CMalaria Journal 2009, 8:53 http://www.malariajournal.com/content/8/1/53
Page 8 of 12
(page number not for citation purposes)
the rat lymphopenia mutation present in the type I diabetic
BB rat, which has been shown to be due to a premature
stop in the GIMAP5  open reading frame [22,23], the
development of a mouse strain bearing a targeted deletion
of the mouse GIMAP5 gene [11] and the use of mouse
reaggregate foetal thymic organ culture to examine GIMAP
gene function by shRNA knockdown [4]. Similarly, evi-
dence from both a knockout mouse strain and a hypo-
morphic rat variant strain has implicated GIMAP4 in the
acceleration of cell death processes in mature T lym-
phocytes [12,13].
The tight genomic clustering of the GIMAP genes within as
little as 100 kb of autosomal DNA prompts the idea that
they are coordinately regulated and participating in
related functional activities. The data on GIMAP4,
GIMAP5 and GIMAP3 [a very close relative of GIMAP5 so
far identified only in mice [4,24]] and their roles in T cell
development lend support to this proposal but corrobora-
tive evidence with respect to the other members of the
GIMAP family is so far lacking. In the case of GIMAP1,
however, the published data on its induction in a mouse
model of malaria infection were consistent with a possible
role in lymphoid (and/or myeloid) cell responses/home-
ostasis [1,6]. A re-examination of these findings was
undertaken, making use of novel serological reagents to
assess GIMAP1 at the protein level. Using the specific mAb
MAC 420, GIMAP1 was shown to be highly expressed in
lymphoid tissues, lung, kidney and heart (Figure 1C),
which is reasonably consistent with published results and
on-line data resources [4,25]. Unlike that of GIMAP4
[15,26], expression of GIMAP1 in the stages of thymic T
cell development showed little variation (Figure 2A), a
result consistent with previously published real-time PCR
analysis [4,13]. By contrast, immature stages in B cell
development expressed less GIMAP1 than mature B cells
(Figure 2A). Purification of spleen cell subsets revealed
similar levels of GIMAP1 expression in T and B lym-
phocytes, modest expression in the F4/80+ macrophage
subset and highest expression (on a per cell basis) in NK/
NKT cells. The immunohistological appearance of normal
spleen showed positive staining in both T and B cell areas,
in agreement with the blotting data from separated cells.
A number of mouse cell lines expressed GIMAP1: these
came from various lineages – T, B, NKT and mast cell –
consistent with the wide distribution seen in lymphoid
tissues (Fig. 2B). The relatively high expression of
GIMAP1 by mature mouse B cells was investigated further
since it contrasted with gene expression data obtained for
rats [15]. Results obtained using both RT-PCR and west-
ern blotting approaches (Figures 6 and 7) suggest that
there may be a concerted up-regulation in the expression
of most if not all the GIMAPs in mature mouse B cells.
This appears to be a species-specific phenomenon since it
was not seen in rats, and reference to on-line gene expres-
sion databases suggests that it is also not a feature of the
expression of GIMAPs in humans [25].
Surprisingly, and despite extensive efforts, we were unable
demonstrate up-regulation of GIMAP1 in an experimental
malaria infection as had been described previously [1,6].
This was the case not only for a primary response to infec-
tion (Figure 3) but also for mice made "immune" to
malaria following the protocol described in the original
papers (Figure 4) and for two differently virulent strains of
the parasite. Indeed, GIMAP1 expression remained stub-
bornly constant despite a variety of treatment schedules
that were tried out (Figure 6). It has to remain a possibility
that an unidentified and uncontrolled variable in the con-
duct of the experiments was responsible for this. In this
regard it is worthy of note that a recently published disser-
GIMAP1 is not up-regulated in C57BL/10 mice immune to  Plasmodium chabaudi infection Figure 4
GIMAP1 is not up-regulated in C57BL/10 mice 
immune to Plasmodium chabaudi infection. C57BL/10 
mice were immunised with erythrocyte ghosts from infected 
mice in Freund's adjuvant. Seven days later the mice were 
infected with Plasmodium chabaudi AS. After nine weeks the 
mice were infected a second time. Seven days post-infection 
the mice were culled and analysed for GIMAP1 expression 
(immune and infected mice). A. Spleen lysates were Western 
blotted with the anti-GIMAP1 mAb MAC420 or anti-β actin. 
B. RNA was extracted from spleens, cDNA was synthesized 
and real-time PCR was used to measure relative GIMAP1 
levels. 'PBS' denotes mice that were given PBS alone instead 
of erythrocyte ghosts and were not infected; 'Freund's' 
denotes mice that were given Freund's adjuvant without 
erythrocyte ghosts and were not infected. Levels of GIMAP1 
were measured relative to the levels of two control genes, 
cirhin and 6-phosphofructokinase.
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tation originating from the laboratory in which the origi-
nal findings were obtained reports a similar failure to
observe GIMAP1 induction [27]. Chemical or microbio-
logical contamination of the P. chabaudi stocks might
have led to the original results but we have failed to up-
regulate GIMAP1 expression in splenocytes in vitro using a
range of Toll-like receptor ligands or cytokines.
Our studies of GIMAP1 have forced a reconsideration of
the conclusions drawn previously about the role that this
gene may be playing in a favoured mouse model of
malaria. Given the evidence for substantially coordinated
regulation of GIMAP gene expression, it seems likely that,
in common with the better-studied family members such
as GIMAP5, GIMAP1 will be shown to participate in the
regulation of apoptosis in lymphomyeloid cells. Data
consistent with this possibility have come from a study in
which cell death was induced in a myeloid leukemic cell
line, LTR6, carrying p53 under the control of a tempera-
ture-sensitive promoter [28]. When p53 expression was
induced by a temperature shift to 32°C, GIMAP1 was one
of several genes that showed increased expression at the
RNA level. After 24 hrs, a 6-fold increase in GIMAP1
mRNA was observed by microarray analysis. Our own
attempts to establish a survival function for GIMAP1 via
siRNA knockdown of its expression have been inconclu-
sive so far. A maximum of only 60% knockdown of pro-
tein expression could be achieved in a cell line, and this
had no effect on the cells' susceptibility to a number of
pro-apoptotic insults (data not shown). Of course, a criti-
GIMAP1 was not up-regulated in mice immune to malaria infection or in mice which had received other combinations of the  treatments to make the mice immune Figure 5
GIMAP1 was not up-regulated in mice immune to malaria infection or in mice which had received other com-
binations of the treatments to make the mice immune. A. Details of the treatment of each group of mice: mice were 
immunised with erythrocyte ghosts from naïve or parasitised mice in Freund's adjuvant, or were given Freund's alone, or PBS. 
Seven days later mice were infected with 106 Plasmodium chabaudi AS parasites (Infection 1, Y), or were given Krebs' saline 
alone (N). After nine weeks mice were infected with 106 Plasmodium chabaudi AS parasites (Infection 2, Y), or were given 
Krebs' saline alone (N). On day 7 post infection mice were culled and analysed for GIMAP1 expression. B. Representative 
spleen lysates were separated by SDS-PAGE and Western blotted with the anti-GIMAP1 mAb MAC420 and anti-β-actin. C. 
The expression of GIMAP1 mRNA in spleen samples was measured by real-time PCR, arbitrarily setting the mean of the two 
Group A samples at 1. Mean values for GIMAP1 expression levels for each group of mice are shown in the lower histogram. 
Mouse group designations are given beneath the histograms.
Y Y Parasitized 4 J
N Y Parasitized 3 I
Y N Parasitized 2 H
N N Parasitized 2 G
N N None (Freund’s) 2 F
Y Y Naïve 2 E
N Y Naïve 3 D
Y N Naïve 4 C
N N Naïve 2 B
N N None (PBS) 2 A
Infection 2 Infection 1 Erythrocyte Ghosts No. 
mice
Group
B
0
1
2
3
4
5
C1 1 C1 2 C1 3 C1 4 C1 5 C2 1 C2 2 C2 3 C2 4 C2 5
R
e
l
a
t
i
v
e
 
l
e
v
e
l
 
o
f
 
G
I
M
A
P
1
C AG F EI H D BJ
0
1
2
3
4
5
R
e
l
a
t
v
e
 
l
e
v
e
l
 
o
f
 
G
I
M
A
P
1
A    B       C  D      E     F    G    H      I          J
C
A
A    B  C   D   E F  G   H    I    J
GIMAP1
actin
37
25
37
50Malaria Journal 2009, 8:53 http://www.malariajournal.com/content/8/1/53
Page 10 of 12
(page number not for citation purposes)
cal survival requirement for GIMAP1 might doom to fail-
ure a simple knockdown approach, since cells in which
this protein has been efficiently forced down might not
survive the selection procedure. It is possible that germ-
line modification methods in mice may be required to
establish the function of GIMAP1.
Conclusion
The reported up-regulation of GIMAP1 expression in
C57BL mouse spleen in response to P. chabaudi [1,6] is
not a robust phenomenon. Defined conditions in which
the effect could be reproduced were sought without suc-
cess. Unfortunately, this experimental malaria system
Relative expression of GIMAP genes in bone marrow B cell subpopulations from C57BL/6 mice Figure 6
Relative expression of GIMAP genes in bone marrow B cell subpopulations from C57BL/6 mice. Real-time PCR 
was used to compare GIMAP gene expression in bone marrow B cell subpopulations with that in lymph node B cells, lymph 
node CD4+ T cells and DN thymocytes. (T cells [black square]; B cells: [grey square]). Bar 1: DN (CD4-CD8-) thymocytes 
(reference); bar 2: lymph node CD4+CD8- T cells (control, strong expression); bar 3: bone marrow pro-B and pre-BI; bar 4: 
bone marrow pre-BII; bar 5: bone marrow immature B; bar 6: bone marrow mature B cells and bar 7: LN CD19+ B cells. (A-
H) Expression levels of, respectively, GIMAP1, GIMAP3, GIMAP4, GIMAP5, GIMAP6, GIMAP7, GIMAP8 and GIMAP9. ↔ Reference 
level (set at 1) corresponding to the DN population. The data are representative of three separate experiments conducted in 
triplicate. Cell populations were purified by FACS using the cell surface markers indicated (or see Fig.2 legend for cell surface 
markers for bone marrow B cell subsets).
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does not appear to be a promising one for the further
investigation of GIMAP  gene function. It also seems
unlikely that the study of this gene family holds particular
promise for our understanding of the resistance to malaria
characteristic of the C57BL strains of mice [29]. The mon-
oclonal antibody MAC420 should prove to be a useful
reagent for the further characterization of the role of this
GTPase in immune cells.
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